Cargando…
Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus
Gemcitabine and docetaxel combination chemotherapy is the standard of care for patients with unresectable recurrent or metastatic leiomyosarcoma of the uterus. Although they are generally well-tolerated agents, they can also cause severe and life-threatening pulmonary toxicities. Here, we describe a...
Autores principales: | Wang, Connor, Rose, Stephen, Mankowski Gettle, Lori, Spencer, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029286/ https://www.ncbi.nlm.nih.gov/pubmed/32089916 http://dx.doi.org/10.1155/2020/4629452 |
Ejemplares similares
-
Solitary CNS Metastasis on Initial Presentation of High Grade Serous Carcinoma of the Fallopian Tube
por: Harl, Felicity, et al.
Publicado: (2018) -
Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines
por: Lopez-Acevedo, Micael, et al.
Publicado: (2014) -
Recurrent intravenous leiomyosarcoma of the uterus in the retrohepatic vena cava
por: Mckenna, Logan R., et al.
Publicado: (2014) -
Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer
por: Li, Fenghu, et al.
Publicado: (2019) -
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
por: Lopez, Gonzalo, et al.
Publicado: (2017)